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Objccdws. Thi study was designed to tat the hypothesis that 
rqwftiw therapy with tbrolnbolysis will prevent he develop 
meat of s&dtiwnt mitral rgqitatlw in patients with inferior 
myocardial infaretiw. 
bfetbcds. We pmspedivcly stwJll 104 patknb with a first 
!nMw mymudinl infarction. Thmmbdytii therapy was admin. 
iskred to $9 pstknts Meatmen group) 3.2 I: 2.1 h aikr the owt 
ti svnmtoms. Tlw other 49 r.atients fwmed th? mntml nwo. 
Mitral regurgitation is a serious complication of acute mgo- 
cardial infarction. The presence of mitral regurgitation after 
acute mymxrdial infarction is associated with the develop- 
ment of hemodynamic deterioration. heart failure and poor 
outcome (1-S). 
Recent repens have suggested that coronary revascular- 
ization with percutaneous tmnshtminal coronary angioplasty 
(6-E) IX coronary bypass grafting (I) may be useful in 
restoring mitral vt.lve competence. improving hemodynam- 
its and increasing suwival in patients with ischemic mitral 
regurgitation. However, the possible protective influence of 
reperfusian therapy with thrombolytic agents has not yet 
been thomughly elucidated. 
_ 
patients, 18 (17%) of I04 patients and I1 (11%) US 100 patients. 
rSpfftNy. 
It is now well established that thmmbolytic thaapy 
administered soon ler acute myocxdial btfat’ction reduces 
the mortality rate and preserves left ventricular fimcticn. 
Although this treatment has been widely accepted in patients 
with auterior wall myocardial infarction, its value in patients 
with inferior zx paste !or wall myocardial infarction has been 
controversial (9-11). Because ischemic mitral regurgitation 
frequently develops in patients with inferior and posterior 
inyocardial infxcaretion (12-15). we hypothesized that success- 
ful reperfusion therapy using intravenous thrombolysis may 
provide benefit by reducing the incidence and severity of 
postinfarction mitral regurgitation. The purpose of the 
present study was w test this hypothesis in patients with a 
first inferior or posterior wall myocardial infarction. 
Methods 
Study patients. Included in this study were patients <76 
yars old with acute inferior, infemposterior. inferalateral or 
extensive posterior (inferoposterior-lateral) wall myocardial 
infarction. Exclusion criteria were I) history of prior myo- available. A frequency of 4 MHz was most often used. 
cardial infarction, 2) bis:ory gf rheumatic heart disease, Doppler ador gain was optimized as described previously 
heart failure, cardiac surgery or percutaneous transluminrd (18). Mitral regurgitation was considered present if blue, 
coronary aogioplasty, and 3) evidence of mitral valve pro- green or mosaic signals were seen originating from the mitral 
lapse or other mitral valve disease. valve agd soreadinn into the left atrium durinn svstolc. 
Inferior myocardial infarction was defined as I) ischemic- Video&es we; carefully analyzed by coo&& of two 
Woe chest oain of X0 min duration. 21 new ST seement exmrienced observers (Z.V. and M.M.) who had no knowl- 
ei&tion >i mV or new Q waves (>30 ms wide and >i mV e&e of the patients’ cl&al, ECG and &jographic data. For 
deep) in leads II, III and aVF on the surface electrocardio- each patient, the maximal area of the regur&aot jet and 
gram (ECG), and 3) serial elevation of serum cardiac creat- regurgitant jet arealeft avial mea in alt three ~laies were 
ine kinase MB levels. measured. Severity of mitral regurgitatioo was graded oo the 
Posterior myocnrdial infarction was defined as new ST basis of the method described by Helmcke et al. (l9), which 
segment elevation >I mV or the development of new Q carrelater Doppler color flow findings with angiogmphic soar- 
waves on ECG leads V,, V, and V, (16). ing. No regu@jtation was &&ted as grade 0; a mitral regur- 
Right ventriculnr infarction was diagnosed by ECG and gitationjetoccupyingS% to 19%. 20% 103% and all@6ofthe 
echocardiography and defined as new ST segment elevation left atrial area represented, respectiveiy, mild (grade I), mod- 
(1 mV) on ECG leads V,R and VIR (17). erele Wade 2) and ee.vere Wade 3) mitral reaumitation. 
Tbromboiytic protocoi. Pad& eligible for thromboiysis M&wemmtatkNveo~utarfunsUnn.-Lift ventricular 
were treated with either intravenous recombinant tissue- eiection fraction was assessed in a subset of li oatieots bv 
type plasminogen activator (r&PA) or streptokinane. A total 
next 5 days using the same pmtocol described for the 
dose of 120 mg of rt-PA was given during a 6-h infusion, 
starting with a IO-mg bolus injection followed by a contintt- 
rt-PA-treated patients. Each patient received oral aspirin 
ous infusion of 50 mg in the 1st h, 20 mg in the 2nd h and 
(250 mg/day) beginning immeJiately on admission. 
IO mg during each of the next 4 h. Concomitantly, heparin 
was infused in a bolus injection of 5,Mw) IIJ and then 
continued at 25,OW ILli24 b. The dose was adjusted to 
Thrombalysis was considered successful if abrupt relief 
maintain the activated partial thromboplastin time at 1.5 to 2 
times the baseline level. Heparin infusion was continued for 
5 days. Streptokinase (I.5 million U) was infused over a 
period of 60 min, followed by intravenous heparin for the 
radionuclide ventriculogmphy at predischarge &aminatia~ 
(7 to 10 days). All radionuclide examittaIians were assessed 
by an experienced cardiologist who had no knowledge ofthe 
clinical data on the examined patient. 
was used to compare the pro&rtion of patienis with a 
particular variable in the Iieatment group with that in the 
Fad~~eprimaryendpointofthestudywastk 
development of significant mitd regurgitation (grade 2 or 3). 
control group. The I test was used to determine differences 
Secondary end points were the Qvelopmcnt of mitral regurgi- 
tation of any grade, as well as in-hospital and follow-up events. 
between the mean values of continuous variables for the two 
StnIlstkal m&hods. The prevalence of potential risk fat- 
tars for significant mitral regurgitation in patients with and 
without thrombolyris was compared. The chi-wusre test 
ofchest pain&wed within90 minof treatment, asdociated 
wilh a decrease in the total ST segment elevation by SSG% 
and an early peak (<I2 h) of creatine kinase of myocordial 
origin (CK-MB). 
Control group. This included all patients with a first 
inferior infarction ineligible for thmmbolydc therapy be- 
cause of either contraindications for thmmbolysis or late 
arrival (26 h) after oneat of chest pain. 
groups. Multivariate logwtic armlysis was subseqtteltly con- 
ducted to identify variables that were independently associ- 
ated with the development of significant mitral regurgitation. 
The variables initially studied were age, gender. diabetes 
mellitus, presence of posterior wall infarction, presence of 
right ventricular infarction, congestive beart failwe, any 
arrhythmias, complete atrioventricular (AV) block, oostmyo- 
cardid infarction ischemia, ~oronaw revascularization and 
Echocardiography. Each pa&t underwent three 
echocardiographic examinations. Echocardiography was 
administration of thrombolytic therapy. 
Adjusted chi-square with p = 0. IS for entry and p = 0.05 
performed within 24 h after the onset of chest pain and was 
repeated at 7 IO IO days and at 28 to 30 days. 
for removal were used, with age and thrambolytic therapy 
forced into the model and other covariates examined in a 
All echocardiographic studies included pulsed Doppler stepwise manner. The LOGlSTlC procedure of the Statisti- 
and color flow imaging as part of the study protocol. Stan- cal Analysis System (SAS version 6) was used to evaluate 
dardized echocardiographic and Doppler examinations were risk coefficients and vield the individual estimated risk 
perfomled using muitipie orthogo&iparasteroal and apical 
views with the patient positioned in the left lateral decubitus 
probabilities (20). . 
position. Commercially available instrumentation was uti- 
lized (Hewlett-Packard) and was operated with either a 2.5.. Results 
3.5 or S-MHz transducer for the conventional echocardio- 
graphic images and a 2.5.MHz transducer for the color Row 
SIudy patients. During the 18-month study period, 462 
studies. Pulse repetition frequewies of 4,6 and 8 MHz were 
patients WIR admitted with documented myocardial i&c- 
tion to the coronary care unit at the Heart Institute, Sheba 
TaMe 1. Clinical Characteristics oi 104 P&ems 
lSi”rnh”lWi 
Medical Center, Tel-Hashomer. Israel. One hundred four- 
teen patients met the entry criteria for eligibility in the study. 
Intravenous thrombolytic therapy was administered to 61 
patients within 3.2 -r 2.1 h after onset of chest pain, 
streptokinase to 45 and rt.PA to 16 patients. Forty-six 
pat&s (75%) were judged to have successful reperfosi& by 
clinical criteria. Fifty-three patients did not receive throm- 
bolytic therapy (control group). 
Eecause 6 patients from the treatment group and 4 
patien!x from the control group were excluded because of 
inadequate eehocardiographie imaging, the study group 
comprised 104 patients (55 patients treated with a thromba- 
lytic agent and 49 control patients). 
Three patients (one in the treatment and two in the 
control arow) died after the sc,ond enamination. One 
patient ii the’ control group missed the follow-up examine- 
tion. Thus, follow-up (28 to 30 days) was carried out in 100 
patients. 
Bwline charaeteristii. Table 1 presents the baseline 
clinical characteristics of the Datients in the treatment and 
control groups. The Iwo groups were gencnlly comparable 
and contained a similar proportion of patients at increased 
risk. 
Incidence of p&&r&i4 ad(rpl 
shows the incidence and severity of mitral rewr&tion 
among lhe stl;dy patients. Mitral regurgitatian orany grade 
developed in 33% (34 of 104 patients) witbin 24 h: Lh ~mpw- 
tion increased to 41% (43 of 104 patients). at 7 to IO days and 
decreased to 33% (33 of IW patients) at 28 to 30 days. 
The overall incidence rates of significant (moderate or 
severe) mitral regurgitation were 10% 110 of 104 patients). 
17% (18 of lo2 patients) and II% (II of to0 patients1 at the 
three study examinations, respectively. 
Clinical predietom -*Led sitb the developmot 0X 
signiticant mitrat reg@Uan. Stepwise lcgistic regression 
analysis of the baseline clinical variables. interventions aad 
in-hospital camplicatiws disclosed several independent risk 
factor< associated with the development of significant mitd 
regurgitation. These risk factocs are &ted in Table 3. 
Aswiation be~era tbmmbelysis aerl the 
si&?cent mitral reew&atiea (Fw. I). Cornpared~with the 
c&rol group. after‘adj&ment f&age. geti&, heart failure 
and complete AV block. patients receiving thmmbolytic 
therapy exhibited a markedly reduced prevalence of sianifi- 
cant mitral regurgitatim at 20 h (16% vi. 4%. odds rati~O.1. 
90% confidence interval (Cl] 0 to 0.7); at 7 to 10 days (24% 
vs. II%. odds ratio 0.3.90% Cl 0.1 to 0.9) and at 28 to 30 
days (15% vs. 7%. odds ratio 0.4, 96% Cl 6.1 to 1.6). 
None of the patients who received thrombvlytic therapy 
developed were mitral regurgitation, whereas five of the 
control patients did (Table 2). 
in-hospital ererds. in-hospital complications, me&z&n 
and proccdurcs in the two groups were generally comparable 
(Table 4). Tbe prevalence of hean failure aad arrhythmias 
was lower in the treatment group, but these Werences did 
no! reach conventional statistical significance (II% vs. 18% 
and 29% vs. 43%. respectively). 
The incidence of comdications such es wstinfarcdon 
ischemia and the use of nit&s or calcium cba~nel blockers, 
which mny et&t the occurrence and swerity of mitral 
regurgitation. was similar in both groups. 
Tsbk 2. lneidrnce and Severily of Mitral Rewrgitation Among 101 Patients 
Table S. Odds Ratios for Devslopmeat of Significant Mitr l 
Regurgitation i  the First Month After a First Inferior Myocardizl 
Infarction 
Effect of eomoary angloplasty on the severity of milral 
iegorgltalion. Percutaneous tmnsluminal coronary angio- 
plasty was performed in eight patients. Before the proce- 
dure, four patients (IWO from the treatment group and two 
from the control group) had significant mitral rqurgitaiion. 
Successful coronary angioplasty abolished the mitral regur- 
gitation in two patients and reduced the severity of mitral 
regurgitztian in one patient. The letl circumflex coronary 
artery was involved in these patients. The single patient in 
whom coronary angioplasty did not reduce the severity of 
mitral regurgitation had total occlusion of the IeR circumflex 
artery and dilation was performed on a lesion in the left 
anterior descending coronary artery. 
Discussion 
The main finding of our study is that thrombolytic therapy 
during a first inferior myocardial infarction is associated with 
a reduced incidence and severity of ischemic mitral regurgi- 
tation. 
Figure 1. Influence of thrombalyais on the prevalence of significant 
mitral regurgitation i 104 patients with a first infer!or myaeardial 
I thrombalysis m control 1 
tation. Mitral regu&itation is a relatively common compli- 
cation of myocerdial infarc:ion: recent reports (M.lS 
15,21,22) soggest hat it has ill incidence rate of 9% to 56%. 
In the present study, the incidence ot significant (moderate 
or severe) mitral regurgihition was 10.6% at 24 h. increased 
to 17% at 7 to 10 days and was 1 I% at 28 to 30 days. When 
significant mitral regurgithtion developed, it never resolved 
spontaneously and sometimes increased in severity from 
moderate to severe. Decreasing swerity of signilicant mitral 
regurgitation was observed only after reperfosion with COT- 
anary angioplasty or bypasr gmftiag. 
Earlier studies (I-5) showed that the presence of mitral 
regurgitation after acute myocardial itiarction is associated 
with severe heart failure and significantly influences short- 
and long-term pmgoosis. Mitral regurgitation may also re- 
Rect ongoing ischemia (3). In the present study, however, 
there were no significaot differen.:c in the prevalence of 
recurrent ischemic episodes or in the results of predischarge 
exercise tests between the treatment and control groups 
fTable 41. 
tlon. Complete AV b&k was assofiated with &&ant 
mitral regwghation at 24 h. This association may be partly 
explained by the development of AV dissociation. In addi- 
tion, heart block during inferior myocardial infarction may 
be a marker for large infarction (23.24). which has been 
attributed to the development of mitral regurgitation after 
myocardial infarction (2). Women exhibited an increased 
incidence of signiiicant mitral regorghalion at 7 to 10 and 28 
to 30 days after infarction. The independent nature of this 
observation is in agreement with previous studies (1,3,4). 
Increased risk for complications and death in women after 
acote myocardial infarction has been demonstrated (25). Tbe 
cause for the higher incidence of mitral regurgitation in 
women than in men remains unknown. 
T&k 4. In-Hospital Events and Interventions* 
nmmtdylr 
Trestmcnt 
I” = 51, 
Heart failure was associated with the occurreocc of size and segmental wall motion. The differences in the 
signitkant mitral regurgitation at 7 to IO days after myocar- disiriaution and severity of asynergy in relation to p:eeseoce 
dial infxretion, when the greatest prevalence of mitral reyr- of mitral regurgitation may provide a fimter foundation for 
gitation was measured (T&e 2). This finding is in accord our observations. However, our study did not attempt to 
win s:uCies demonstrating a high incidence of congestive delineate the mechanism of ischemic mitral regurgitation, 
heart failure (31, a large infarction (2), a higher end-diastolic which is multifactorial and may vary depending ou individual 
volume (5) and a lower left ventricular eicction haction clinical characteristics. 
(5,21) an&g patients with mitrul regurgitation after acute 
myocardial infarctmu. However. :I is unclear whether mural 
regur&atiau or beart failure is the primary cause. 
E&i of tlwomboly* on isrhemic Initial regurgitation. 
There are SDI~ISC and discordant data as to the effect of 
throutholysi~ on the development of postinfarction mitral 
reeurzitation. h oreliminarv rcuori (22) from the Thrombol- 
y& ii Myocardisl Infarcti& (+LMIj Phase 1 trial described 
132 patients with a first myocardial infarction who received 
thmmbolytic :herapy. The presence of mitral regurgitation 
was indepeoden: of coronary artery patency before ar.d after 
thrombolysis. Early mitral regurgitation resolved in 57% of 
patients within IO days. This resolution was also indepen- 
dent of successful corunwy artery repetfusion. 
Hickey et al. II) reported on the effect of thrombolytic 
treatment or emergency angioplasty, or bath, in 63 patients 
with sianificant ischemic mitral rwtrgitation. In all but nine 
pati& reperfusion was achieveiwihiu 24 h of the onset of 
ischemia. These nine patients underwent urgent sngioplasty 
wit&t 21 days of infarction. In four of the nine patients 
receiving delayed reperfusion. mitral regurgitation resolved 
completely after repetfusion. Follow-up ventticulugraphy 
demonstrated a significant reduction in regurgG+tion in the 
patients with successful reperfusion and a trend was per- 
ceived for improved short- and long-term sur~ivval with 
reperfision th&py. Hickey et ul. (IL however, did not 
clearly d&rentiate between the outcome of patients treated 
with thmmbolysis versus angioplasty. 
The mechanisms bv which thrombolvsis mav mevettt the 
development of n&l regurgitation are not &r. On the 
basis of current concepts of papillary muscle dysfunction 
(1,2,15), we speculate that successful reperfusion prevents 
the development of mitral regurgit?dion by limiting infwct 
size, attenuating stunnirlg and preventing infarct expansion 
and dyskinesia. especially in areas of myocardium support- 
ing the papillary muscles. 
LAmi- of the study. The major limitation of our 
study is the absence of a randomized controlled comparison. 
However. becaure thmmbolvsis is now firmly established us 
life-saving therapy for acutemyocardiul inf&tion, nndom- 
ization of patients to this treatment has been rendered 
ethically unfeasible. 
The lack of immediate coronary augiogmphy is another 
considerable limitation. This procedure would have helped 
to correlate the prevalence and severity of tttitnl regurgita- 
tion with the success of lytic therapy, patency of the culprit 
infarct-related artery and possible value of late spontaneous 
recanalizution in the absence of early reperfusion. 
Another shortcoming is lack of data on left ventricular 
Coucludom amI iqtlicak This study is the first to 
indicate the benefit of thmmbolytic therapy in the treatment 
of ischemic mitral regurgitation m patients with acute infe- 
rior myocardial infarction. The best approach to irchemic 
mitral regurgitation is to prevent its occttrrentx. Thmmbo- 
&tic therapy has several advantages over other means of 
treatment for Lschemic mittal regurgitation. Thrombolysis is 
safer and may result it, earlier repetision than occurs with 
other means. Reestablishment of blood flow in the target 
artery is associated with a high pmbabi!ip; of recovery of 
valve competence and obviates the need for mechanical 
revascultization or valve prwedures. In view of the present 
findings, we support the use of thrombolyric therapy in 
patients with inferior myocardial infarction. 
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